Rahul Sakla

10PUBLICATIONS
13CO-AUTHORS
Molecular targetsCharacterisation of biological macromoleculesCancer therapy (excl. chemotherapy and radiation therapy)Groundwater quality processes and contaminated land assessmentInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 29, 2025
Beta-Sitosterol-Conjugated Sinapic Acid-Engineered Nanoliposome: Biomucoadhesive and Enzyme-Responsive Targeted Oral Therapy in Ulcerative Colitis.

Kanika, Ajay Kumar, Anas Ahmad

|Mar 04, 2025
Engineered Drug-Amphiphile Conjugate Nanoparticles for Targeted Inhibition of AQP4-Mediated NLRP3 Inflammasome Signaling in Collagen-Induced Rheumatoid Arthritis.

Ajay Kumar, Rahul, Kanika

|Feb 25, 2025
Multifunctional chrysin-loaded gallic acid-glycerol monostearate conjugate-based injectable hydrogel for targeted inhibition of hypoxia-induced NLRP3 inflammasome in ulcerative colitis.

Ajay Kumar, Rahul, Kanika

|Jul 13, 2024
Benzothiazole-Quinoline-Based Fluorescent Probe for Fe<sup>3+</sup> and its Applications in Environmental and Biological Samples.

Nidhi Nehra, Rahul Kaushik, Kanika

|Apr 27, 2023
NLRP3 Inflammasome-Targeting Nanomicelles for Preventing Ischemia-Reperfusion-Induced Inflammatory Injury.

Ravi Prakash, Akshay Vyawahare, Rahul Sakla

|Dec 06, 2022
Caffeic Acid-Conjugated Budesonide-Loaded Nanomicelle Attenuates Inflammation in Experimental Colitis.

Rakesh Kumar Mishra, Anas Ahmad, Kanika

Pageof 2

Frequent Collaborators

5 joint publications

Rehan Khan

4 joint publications

Ajay Kumar

4 joint publications

D Amilan Jose

3 joint publications

Anas Ahmad